Examkin

Soru

Zorluk: OrtaRheumatology and Immunology

A 28-year-old female patient with established systemic lupus erythematosus comes to the office reporting recent-onset leg swelling and foamy urine. Her blood pressure is 150/92150/92 mm Hg. Urinalysis reveals 3+ protein and the presence of red blood cell casts. Arrange the following steps in the most appropriate clinical sequence for the evaluation and management of this patient's new complication.

  1. 1Quantify proteinuria and assess baseline renal function (e.g., spot urine protein-to-creatinine ratio).
  2. 2Perform an ultrasound-guided percutaneous renal biopsy.
  3. 3Initiate induction therapy with high-dose glucocorticoids and an immunosuppressive agent (e.g., mycophenolate mofetil).
  4. 4Transition to maintenance immunosuppression (e.g., lower-dose mycophenolate mofetil or azathioprine).

Cevap

The correct sequence is: quantify proteinuria, perform renal biopsy, initiate induction therapy, and finally transition to maintenance therapy.
The correct clinical sequence for managing suspected lupus nephritis begins with non-invasive confirmation of renal disease (quantifying proteinuria and assessing creatinine). Because the clinical presentation does not reliably predict the histopathologic class, a renal biopsy must be performed next. The biopsy results guide the initiation of aggressive induction therapy for severe disease (Classes III/IV). Finally, after 3 to 6 months of successful induction, the patient is transitioned to a lower-dose, less toxic maintenance therapy to sustain remission.

Adım Adım Çözüm

1
Identify the clinical presentation.
The patient has systemic lupus erythematosus with new edema, hypertension, and red blood cell casts, indicating active glomerulonephritis (lupus nephritis).
Recognizing the complication dictates the immediate need for a structured renal workup.
2
Determine the initial diagnostic step.
Quantify the proteinuria and assess renal function via non-invasive testing.
Non-invasive confirmation of severity is required before exposing the patient to the risks of invasive testing.
3
Determine the definitive diagnostic step.
Perform a percutaneous renal biopsy.
Clinical features alone cannot reliably differentiate the histologic classes of lupus nephritis (Classes I through VI), which require vastly different treatments.
4
Determine the initial therapeutic intervention.
Initiate induction therapy.
Active, severe lupus nephritis (e.g., Class III or IV) requires aggressive, high-dose immunosuppression to prevent irreversible nephron loss.
5
Determine the long-term management strategy.
Transition to maintenance therapy.
Once remission is achieved (usually after 3-6 months), stepping down to a less toxic maintenance regimen prevents disease flares while minimizing medication toxicity.

Anahtar Kavram

Sequential evaluation and stepwise pharmacologic management of Lupus Nephritis
Tahmini Süre:1m 0s
Bu soruyu puanla

Konular

Rheumatology and Immunology

Bu konudan daha fazla soru